Optimeos
Princeton, US · Founded 2018 · 10 employees on LinkedIn · 3 known investors
Find your way into Optimeos
668 people in our graph share verified history with the Optimeos team — schools, employers, funds. One of them is your warm intro.
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity. Its technology enables intracellular and long-acting delivery for pharmaceutical and biotech partners addressing challenges like tissue targeting and dosing profiles.
Founders & leadership
Optimeos was founded in 2018 by Robert K. Prud'homme, PhD, Bob Prud'homme, Rob Pagels, and Chet Markwalter.
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 4 rounds · 2020–2026
▶$1MraisedJun 2026 · 1 investors · BiotechnologyRule 506(b)
- Jason SmithDirector
- Shahram HejaziExecutive Officer, Director
- Robert K Prud'hommeDirector
- Benjamin DoranzDirector
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedNov 2024 · 5 investors · BiotechnologyRule 506(b)
- Benjamin DoranzDirector
- Shahram Hejazi, PhDExecutive Officer, Director
- Jason Smith, PhDDirector
- Robert K. Prud'homme, PhDDirector
- Offering amount
- $5M
- Amount sold
- $2.9M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$175KraisedJun 2021 · 4 investors · BiotechnologyRule 506(b)
- Jason Smith, PhDDirector
- Robert K Prud'homme, PhDDirector
- Shahram Hejazi, PhDExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $175K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$270KraisedAug 2020 · 3 investors · BiotechnologyRule 506(b)
- Robert Prud'homme, PhDDirector
- Jason Smith, PhDDirector
- Shahram Hejazi, PhDExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $270K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Optimeos went on to found or lead other companies.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2023 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $287.7K |
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $255.4K |
| National Science Foundation | Phase ISTTR | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Hatch BioFund Invests in Gene Delivery Startup Optimeos - MyChesComychesco.com · Jul 2026
Hatch BioFund Invests in Optimeos Life Sciences to Advance Nanoparticle Drug Delivery Platform | citybizcitybiz.co · Jun 2026
Optimeos Life Sciences Receives Investment From Hatch BioFundfinsmes.com · Jun 2026Frequently asked questions
- What does Optimeos do?
- Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity. Its technology enables intracellular and long-acting delivery for pharmaceutical and biotech partners addressing challenges like tissue targeting and dosing profiles.
- Who founded Optimeos?
- Optimeos was founded by Robert K. Prud'homme, PhD, Bob Prud'homme, Rob Pagels, Chet Markwalter in 2018.
- Who are Optimeos's investors?
- Optimeos's investors include 7G BioVentures, Anzu Partners, Hatch BioFund.
- How much funding has Optimeos raised?
- Optimeos has disclosed $4.4M raised across 4 rounds.
- Where is Optimeos headquartered?
- Optimeos is headquartered in Princeton, US.